An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images As a port strike stretching from New England to Texas halted nearly half of all trade coming into the U.S., customs data shows that critical medical devices and drug components for the booming, expensive weight-loss and diabetes drugs … Read more
Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity — especially women — has climbed since a decade ago, according to new government research. The U.S. obesity rate is about 40%, according to a 2021-2023 survey of about 6,000 people. Nearly 1 in 10 of those surveyed … Read more
Mention pregnancy and food in the same breath, and the common phrase of ‘eating for two’ will probably spring to mind. But a ground-breaking new study indicates this may be a worrying oversimplification. Scientists have now warned that pregnant mothers who are clinically obese or consume too much fat or sugar may put their babies … Read more
Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 100 shares of LLY, decreasing its weighting to 2.85% from about 3.13%. Now that we are no longer restricted, we are selling some Eli Lilly shares. We downgraded Lilly … Read more
Traders work on the floor of the New York Stock Exchange during morning trading on August 20, 2024 in New York City. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no … Read more
Traders work on the floor of the New York Stock Exchange during morning trading on Aug. 20, 2024. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. … Read more
WASHINGTON — Two years ago, Pfizer was the envy of the pharmaceutical world, with more than $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid. Today, CEO Albert Bourla is trying to turn the page from that success story, which has turned into more of a financial headache for the global drugmaker. … Read more
A significant study of British people’s sleeping patterns has revealed that over half of individuals who have difficulty falling asleep at the right time, or who spend hours in bed longer than usual, are at an increased risk of developing type 2 diabetes. The research, conducted by university scientists in Manchester and Boston, analysed years … Read more
If Indians don’t lose weight, they can forget about becoming a developed economy, a long-term goal set by the government. It”s widely argued that it is the Indian economy’s moment to shine because it has a big demographic dividend, and a large population of youth which can turn into a huge productivity boost, especially when … Read more
Restaurant critics appear to have the best job in journalism, enjoying meals a few nights a week on someone else’s dime. But New York Times restaurant critic Pete Wells had painted a more complicated picture. In a recent column, Wells announced he’s leaving the beat because the constant eating has led to obesity and other … Read more
